Lilly Singapore purchased Partek GS to analyze genomic data collected through various stages of drug trials. Known for their excellence in research and pharmaceuticals, Lilly has facilities around the world, and is headquartered in Indianapolis, Indiana, USA.
Partek GS is designed to import, analyze, and visualize high-dimensional genomic data. It is Affymetrix GeneChip-compatibleTM for exon, gene expression, chromosomal copy number, and tiling array analysis. Partek GS can analyze SNP data as well.
Partek Incorporated is a leading provider of statistical analysis and interactive data visualization software for the scientific research community. Partek software enables researchers to quickly identify and quantify patterns in data, including data resulting from genomic and proteomic studies, high-throughput screening campaigns, and computer aided drug design. Partek is located in St. Louis, Missouri.
CONTACT INFORMATION: Marketing Communications Partek Incorporated 314-878-2329 314-275-8453 www.partek.com